Maintenance infliximab for Crohn's disease: The ACCENT I randomised trial

Stephen B. Hanauer*, Brian G. Feagan, Gary R. Lichtenstein, Lloyd F. Mayer, S. Schreiber, Jean Frederic Colombel, Daniel Rachmilewitz, Douglas C. Wolf, Allan Olson, Weihang Bao, Paul Rutgeerts

*Corresponding author for this work

Research output: Contribution to journalArticlepeer-review

3422 Scopus citations

Fingerprint

Dive into the research topics of 'Maintenance infliximab for Crohn's disease: The ACCENT I randomised trial'. Together they form a unique fingerprint.

Medicine & Life Sciences